These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1577071)

  • 21. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
    Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
    Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exact prediction of a natural T cell epitope.
    Rötzschke O; Falk K; Stevanović S; Jung G; Walden P; Rammensee HG
    Eur J Immunol; 1991 Nov; 21(11):2891-4. PubMed ID: 1718764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of hapten-anchoring peptides in defining hapten-epitopes for MHC-restricted cytotoxic T cells. Cross-reactive TNP-determinants on different peptides.
    Martin S; Ortmann B; Pflugfelder U; Birsner U; Weltzien HU
    J Immunol; 1992 Oct; 149(8):2569-75. PubMed ID: 1383319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
    Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
    Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen processing mutant T2 cells present viral antigen restricted through H-2Kb.
    Zhou X; Glas R; Liu T; Ljunggren HG; Jondal M
    Eur J Immunol; 1993 Aug; 23(8):1802-8. PubMed ID: 8393799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity.
    Alexander-Miller MA; Burke K; Koszinowski UH; Hansen TH; Connolly JM
    J Immunol; 1993 Jul; 151(1):1-10. PubMed ID: 8392095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
    J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of accessory cell processing and presentation of shed H-2 alloantigens in allospecific cytotoxic T lymphocyte responses.
    Golding H; Singer A
    J Immunol; 1984 Aug; 133(2):597-605. PubMed ID: 6203969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant.
    Nikolić-Zugić J; Carbone FR
    Eur J Immunol; 1990 Nov; 20(11):2431-7. PubMed ID: 2253683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-associated E6 protein of human papillomavirus type 16 contains an unusual H-2Kb-restricted cytotoxic T cell epitope.
    Gao L; Walter J; Travers P; Stauss H; Chain BM
    J Immunol; 1995 Dec; 155(12):5519-26. PubMed ID: 7499833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I molecules.
    Newberg MH; Ridge JP; Vining DR; Salter RD; Engelhard VH
    J Immunol; 1992 Jul; 149(1):136-42. PubMed ID: 1607650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression levels of stress protein gp96 are not limiting for major histocompatibility complex class I-restricted antigen presentation.
    Lammert E; Arnold D; Rammensee HG; Schild H
    Eur J Immunol; 1996 Apr; 26(4):875-9. PubMed ID: 8625982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of self peptides in the allogeneic cross-reactivity of CTLs.
    Kuzushima K; Sun R; van Bleek GM; Vegh Z; Nathenson SG
    J Immunol; 1995 Jul; 155(2):594-601. PubMed ID: 7541821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes.
    Bachmann MF; Lutz MB; Layton GT; Harris SJ; Fehr T; Rescigno M; Ricciardi-Castagnoli P
    Eur J Immunol; 1996 Nov; 26(11):2595-600. PubMed ID: 8921944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic T lymphocyte responses to wild-type and mutant mouse p53 peptides.
    Bertholet S; Iggo R; Corradin G
    Eur J Immunol; 1997 Mar; 27(3):798-801. PubMed ID: 9079825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of alpha 1 with alpha 2 region in class I MHC proteins contributes determinants recognized by antibodies and cytotoxic T cells.
    Stroynowski I; Clark S; Henderson LA; Hood L; McMillan M; Forman J
    J Immunol; 1985 Sep; 135(3):2160-6. PubMed ID: 2410513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity of peptide presentation by a set of hybrid mouse class I MHC molecules.
    Maryanski JL; Abastado JP; Kourilsky P
    Nature; 1987 Dec 17-23; 330(6149):660-2. PubMed ID: 3500418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-restricted recognition of viral antigens in HLA transgenic mice.
    Kievits F; Ivanyi P; Krimpenfort P; Berns A; Ploegh HL
    Nature; 1987 Oct 1-7; 329(6138):447-9. PubMed ID: 2821399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic T lymphocyte recognition of HLA-A2 antigens in normal and HLA-Cw3-transgenic mice.
    Hämmerling GJ; Hunt T; Dill O; Moreno J
    Eur J Immunol; 1989 Apr; 19(4):599-604. PubMed ID: 2786469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.
    Kast WM; Boog CJ; Roep BO; Voordouw AC; Melief CJ
    J Immunol; 1988 May; 140(9):3186-93. PubMed ID: 2834454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.